Synthetic Blood International, Inc. is a cutting edge biomedical product development company specializing in creating innovative pharmaceuticals and medical devices in the fields of oxygen therapeutics, blood substitutes, liquid ventilation and implanted glucose sensing. Once these sophisticated products reach the market, they promise to revolutionize treatment of such disease states as diabetes, acute respiratory distress syndrome, stroke, myocardial infarction, and many malignant tumors.

Contact Information

3189 Airway Avenue
Building C
Costa Mesa, CA 92626

tel: 714-427-6363
fax: 714-427-6361


Investor Relations



Exchange: OTCBB
Industry: Research Services
Market Cap: $124.7M

The information provided here has been obtained from publicly available sources as well as directly from issuers in some cases. Please see our Disclaimer and Terms of Service for more information.